Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Neck pain

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    126 result(s) found for: Neck pain. Displaying page 1 of 7.
    1  2  3  4  5  6  7  Next»
    EudraCT Number: 2010-022794-34 Sponsor Protocol Number: 862-P-201 Start Date*: 2011-03-04
    Sponsor Name:Novartis Consumer Health
    Full Title: A randomized, double-blind, placebo-controlled, multi-center parallel group phase IV study to evaluate the efficacy and safety of Voltaren® Schmerzgel 1.16% gel in subjects with acute neck pain
    Medical condition: Acute neck pain, present for at least 12 hours. An acute condition is defined as pain shorter than 3 months [CPMP, 2002]. Neck pain is defined as stiffness and/or pain felt dorsally in the cervical...
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10028836 Neck pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-000404-25 Sponsor Protocol Number: 1358.1 Start Date*: 2016-05-02
    Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG
    Full Title: A randomized, controlled multi-centre parallel group study to assess the efficacy and safety of multiple doses of a topically applied combination containing diclofenac 2% + capsaicin 0.075% (2 g fo...
    Medical condition: Acute back pain or acute neck pain
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000019085 10000683 Acute back pain LLT
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10028836 Neck pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-000023-33 Sponsor Protocol Number: PIR-BO-11-001 Start Date*: 2011-11-02
    Sponsor Name:S.P.A. ITALIANA LABORATORI BOUTY
    Full Title: Clinical trial to evaluate, in patient suffering of neck pain the therapeutic equivalence, tolerability and satisfaction of subjects treated by medicated plaster containing piroxicam or diclofenac.
    Medical condition: cervical pain of osteoarthritic origin
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10008322 Cervicalgia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-003707-18 Sponsor Protocol Number: Evelien05 Start Date*: 2014-04-22
    Sponsor Name:
    Full Title: Absorption of sublingual delivered fentanyl (Abstral®) in head and neck cancer patients treated with curatively aimed chemo-radiotherapy
    Medical condition: head and neck cancer patients treated with chemo-radiotherapy
    Disease: Version SOC Term Classification Code Term Level
    16.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004738-15 Sponsor Protocol Number: ADO WAD No-of-1 Start Date*: 2005-02-03
    Sponsor Name:Karolinska University Hospital, Huddinge
    Full Title: Intermittent intravenous adenosine with prolonged pain in the back of the neck with allodynia/dysaesthesia.
    Medical condition: Prolonged pain in the neck caused by a whiplash trauma or another muscle injury.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000078-36 Sponsor Protocol Number: protocol2tdn Start Date*: 2015-03-17
    Sponsor Name:Thomas Fichtner Bendtsen
    Full Title: Analgetisk effekt af proksimal supplerende nervus obturatorius blokade efter insufficient analgetisk effekt af nervus femoralis blokade hos patienter med hoftenær femurfraktur
    Medical condition: Pain in patients with hip fracture
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004863 10017284 Fractured femoral neck LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-005483-21 Sponsor Protocol Number: 15-2021 Start Date*: 2022-01-05
    Sponsor Name:Akershus University Hospital
    Full Title: Chiropractic spinal manipulative therapy for acute neck pain: a 4-armed clinical placebo randomized controlled trial
    Medical condition: Acute neck pain
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NO (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-003965-21 Sponsor Protocol Number: 20VADS04 Start Date*: 2021-01-11
    Sponsor Name:INSTITUT CLAUDIUS REGAUD
    Full Title: Phase II Randomized Controlled Study Aiming to Evaluate the Interest of Qutenza in Patients With ORL Cancer in Remission and With Sequellae Neuropathic Pain.
    Medical condition: Head and neck cancer
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2015-005110-30 Sponsor Protocol Number: FASTRELIEF Start Date*: 2017-02-23
    Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI"
    Full Title: A multicenter randomized trial to evaluate the efficacy of fentanyl pectin nasal spray (FPNS) versus Physician Choice (PC) - Usual Care (UC), in reducing incidental predictable breakthrough pain (I...
    Medical condition: Patients with head and neck cancer .
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-001702-18 Sponsor Protocol Number: protocol1tdn Start Date*: 2014-08-28
    Sponsor Name:Thomas Fichtner Bendtsen
    Full Title: Analgesic duration of a preoperative single-shot femoral nerve block with Bupivacaine and adjuvant Dexamethasone in patients with hip fracture
    Medical condition: Pain in patients with hip fracture
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004863 10017284 Fractured femoral neck LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-000744-26 Sponsor Protocol Number: CBKM120H2201 Start Date*: 2013-08-28
    Sponsor Name:Novartis Pharma Services AG
    Full Title: Phase II multicenter randomized, double blind, placebo controlled study assessing the efficacy of buparlisib (BKM120) plus paclitaxel vs. placebo plus paclitaxel in patients with platinum pre-treat...
    Medical condition: recurrent or metastatic head and neck cancer squamous cell carcinoma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Prematurely Ended) ES (Completed) IT (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) IE (Prematurely Ended) PL (Prematurely Ended) FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004149-33 Sponsor Protocol Number: 05-FNF-007 Start Date*: 2006-01-30
    Sponsor Name:Stryker Biotech, LLC
    Full Title: A randomized, controlled trial of the effect of Osigraft when used in the treatment of displaced femoral neck fractures – a pilot study
    Medical condition: Displaced femoral neck fractures are classified as Garden III and IV according to the Garden classification system for femoral neck fractures.
    Disease: Version SOC Term Classification Code Term Level
    8.0 10016450 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-001116-65 Sponsor Protocol Number: B3D-MC-GHDQ Start Date*: 2012-02-10
    Sponsor Name:Eli Lilly and Company
    Full Title: Second study on the Effect of Teriparatide on Femoral Neck Fracture Healing
    Medical condition: Low trauma femoral neck fracture
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004863 10068399 Trochanteric femoral fracture LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) BE (Completed) GR (Completed) PL (Completed) NL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-002304-89 Sponsor Protocol Number: protocol2_2tdn Start Date*: 2015-07-30
    Sponsor Name:Thomas Fichtner Bendtsen
    Full Title: Preoperative analgesic affect of combined obturator and femoral nerve block compared to femoral nerve block alone, in patients with hip fracture.
    Medical condition: Hip fracture
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004863 10017284 Fractured femoral neck LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-001857-22 Sponsor Protocol Number: Methadone-010922 Start Date*: 2022-09-06
    Sponsor Name:Sygehus Sønderjylland, Orthopedic department
    Full Title: Perioperative Methadone for ameliorating postoperative pain and reduction in postoperative opioid consumption in hip fracture patients – Dosage adjusting pilot-study
    Medical condition: Hip fractures
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10068399 Trochanteric femoral fracture LLT
    25.0 100000004863 10086938 Pertrochanteric femoral fracture LLT
    25.0 100000004863 10086939 Intertrochanteric femoral fracture LLT
    20.1 100000004863 10017284 Fractured femoral neck LLT
    20.1 100000004863 10053653 Femur fracture subtrochanteric LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-021395-28 Sponsor Protocol Number: B3D-MC-GHDN Start Date*: 2012-04-03
    Sponsor Name:Eli Lilly and Company
    Full Title: Effect of Teriparatide on Femoral Neck Fracture Healing
    Medical condition: Low trauma femoral neck fracture
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022117 - Injury, poisoning and procedural complications 10016450 Femoral neck fracture PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) ES (Completed) LV (Completed) FI (Completed) NO (Completed) LT (Completed) EE (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-013462-25 Sponsor Protocol Number: MW001 Start Date*: 2009-09-28
    Sponsor Name:NHS Greater Glasgow and Clyde Health Board
    Full Title: A dose finding study for ultrasound guided anterior psoas compartment blocks in patients with a fractured neck of femur
    Medical condition: Proximal traumatic fractured neck of femur
    Disease: Version SOC Term Classification Code Term Level
    10029173 Nerve block LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-013134-24 Sponsor Protocol Number: RGHT000675 Start Date*: 2009-07-31
    Sponsor Name:Belfast Health & Social Care Trust
    Full Title: Comparison of fascia iliaca compartment block or femoral nerve block using levobupivacaine for postoperative analgesia after operative repair of femoral neck fracture: a dose response study
    Medical condition: Postoperative Analgesia in patients undergoing operative repair of fractured neck of femur
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-002346-42 Sponsor Protocol Number: P2HNC01 Start Date*: 2014-09-12
    Sponsor Name:Copenhagen University Hospital, Hvidovre
    Full Title: Clinical trial with lozenges as local pain treatment for head and neck cancer patients with oral mucostis
    Medical condition: Oral pain due to oral mucositis in head and neck cancer patients which are undergoing radiation therapy
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004856 10028130 Mucositis oral LLT
    17.1 10022117 - Injury, poisoning and procedural complications 10037763 Radiation mucositis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-003589-10 Sponsor Protocol Number: D419LC00001 Start Date*: 2015-12-11
    Sponsor Name:AstraZeneca AB
    Full Title: A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic S...
    Medical condition: Adult patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) who have not received prior systemic chemotherapy.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Completed) GR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) BE (Completed) PL (Completed) AT (Completed) RO (Completed) FR (Completed) PT (Completed) BG (Prematurely Ended) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue May 20 00:54:51 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA